Sample release Reagent
Product Name
Macro & Micro-test sample dimittis Reagent
Certificatorium
CE, FDA, NPA
Principalis components
| Nomen | Principalis components | Componenscubits | Quantitas |
| Sample Releasereagent | Dithiothreitol, sodium dodecycylsulfate (SDS), RNase inhibitor:surfactant, purificatus aquam | 0.5ml / phialam | L fialam |
Nota: components in diversis batches kits non convertitur.
PRAECLUSIO condiciones et PLUTEUM vitae
Copia et onerariis ad locus temperatus. In fasciae vita est XXIV menses.
COMPRESSUS
Instrumentis et apparatu per specimen processus, ut Pipettes, Vortex mixers,aquam balneis etc.
Sample Requirements
Oropharyngeus nuper collected oropharyngeum, nasopharyngeal swabs.
Praecisione
Cum hoc ornamentum est usus ad extractionem ex in-Domus praecisione reference CV ad X replicates, coefficiens variation (cv,%) de CT valore non plus quam X%.
Inter batch difference
Cum in-Domum praecisione referat est probata in tres batches de kits sub iudicio productio in repetita extraction et, coefficiens variation (cv,%) de CT valorem non plus X%.
ERECTIO
● extraction efficientiam existimat
| Efficens comparet magnetica grana methodo et Sample releaturer | ||||
| concentratio | Magna grana methodo | Sample ReleaseR | ||
| orfab | N | orfab | N | |
| (XX) | 28.01 | 28.76 | 28.6 | 29.15 |
| MM | 31.53 | 31.9 | 32.35 | 32.37 |
| D | 33.8 | 34 | 35.25 | 35.9 |
| CC | 35.25 | 35.9 | 35.83 | 35.96 |
| C | 36.99 | 37,7 | 38.13 | individuus |
Et extraction efficientiam de Sample releatus esset similis, ut magnetica grana methodo, et concentration of pathogen esse 200Copies / ml.
● CV valorem collatio
| Repeatability de Sample releaseR extraction | ||
| Concentration: 5000copies / ml | Orf1ab | N |
| 30.17 | 30.38 | |
| 30.09 | 30.36 | |
| 30.36 | 30.26 | |
| 30.03 | 30.48 | |
| 30.14 | 30.45 | |
| 30.31 | 30.16 | |
| 30.38 | 30.7 | |
| 30.72 | 30.79 | |
| CV | 0.73% | 0.69% |
Cum probata ad 5,000 copies / ml, cv of Orfab et n 0,73% et 0,69%, respectively.
